View Post

2 Trials, Now Enrolling, Aimed at Improving Breast Cancer Prevention, Diagnosis, and Treatment

In Clinical Trials by Barbara Jacoby

By: Patricia Inacio, PhD From: breastcancer-news.com The University of Hawaiʻi Cancer Center is enrolling participants in two clinical trials to test new ways of preventing and diagnosing breast cancer, as well as improving current treatments. “These trials are very important because breast cancer is a significant issue in Hawaiʻi,” Randall Holcombe, director of the UH Cancer Center said in a press release. “Racial and ethnic minority …

View Post

Aileron Enters Clinical Trial Collaboration With Pfizer To Evaluate ALRN-6924 In Combination With IBRANCE® (Palbociclib) In MDM2-Amplified Cancers

In Clinical Trials by Barbara Jacoby

Source: Aileron Therapeutics, Inc. From: clinicalleader.com Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized, cell-permeating peptides to treat cancer and other diseases, today announced that it has entered into a clinical trial collaboration with Pfizer to evaluate the combination of Aileron’s ALRN-6924 and Pfizer’s palbociclib, also known as IBRANCE®, in MDM2-amplified cancers. Overexpression of MDM2 in …

View Post

Scientists may have found a way to treat cancer without chemotherapy by replicating our body’s own self-destruct system

In In The News by Barbara Jacoby

By: Lisa Schönhaar From: businessinsider.com Every day, millions of cells in our bodies “kill themselves” and are quickly removed. While the mechanism may sound melodramatic, in reality it’s for our own good. This is because the process ensures potentially harmful cells destroy themselves and, as a consequence, we’re protected from disease. Cancer cells, however, can protect themselves from self-destruction by …

View Post

Cancer: Brain-derived compounds show surprising benefits

In In The News by Barbara Jacoby

Source: Veterans Affairs Research Communications From: sciencedaily.com A lab team led by Nobel Prize winner Dr. Andrew Schally at the Miami Veterans Affairs Healthcare System and the University of Miami showed that a synthetic compound based on a brain hormone spurred the growth of cancer cells in Petri dishes but enigmatically had the opposite effect in mice. The surprising discovery, …

View Post

Physician Releases Fresh Perspective on Cancer Treatment in New Book

In In The News by Barbara Jacoby

Dr. Alexandre Rushenas, M.D., lays bare common notions of the disease as a ‘fight’ and draws on the healing power of the cellular response to authentic emotions and unconditional love in “Cancer, I Love You” A Canada-based author and medical doctor who works in emergency medicine has released an inspirational and revolutionary approach to cancer that aims to help others …

View Post

Program Offers Rides to Cancer Patients To, From Treatment

In In The News by Barbara Jacoby

By: MARIA CLARK, NOLA.com/The Times-Picayune From: usnews.com Robert Boatner has some radiation treatment left to go. The therapy he was prescribed to treat his prostate cancer requires him to travel from his home in New Orleans East to Touro Hospital, Monday through Friday, for a total of 40 days. If he were to miss a single day of treatment, he …

View Post

Often-overlooked Natural Killer cells may be key to cancer immunotherapy

In In The News by Barbara Jacoby

Source: The Ottawa Hospital From: sciencenewsdaily.com Immune checkpoint inhibitors are revolutionizing the treatment of cancer, but new research challenges the central dogma of how these drugs work. This research, published in the Journal of Clinical Investigation, shows for the first time that often-overlooked immune cells called Natural Killer (NK) cells play a crucial role in responding to checkpoint inhibitors. “Checkpoint inhibitors …

View Post

How Searching for a Mutation Can Help Cancer Treatment

In In The News by Barbara Jacoby

From: European Society for Medical Oncology (ESMO) Making the right therapeutic choice based on a tumour’s DNA Individualised therapies that target the specific genetic features of tumours have the potential to transform cancer diagnosis, treatment and care. Several challenges still need to be overcome before these approaches can be widely used in the clinic. Two DNA testing programmes have been implemented in …

View Post

New cancer treatment uses enzymes to boost immune system and fight back

In In The News by Barbara Jacoby

Source: University of Texas at Austin From: phys.org Researchers at The University of Texas at Austin have developed a new approach to treating cancer using enzyme therapy. The enzyme, PEG-KYNase, does not directly kill cancer cells but instead empowers the immune system to eradicate unwanted cells on its own. PEG-KYNase is designed to degrade kynurenine, a metabolite produced by numerous …